Lung Neoplasm Malignant
22
8
8
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
13.6%
3 terminated out of 22 trials
66.7%
-19.8% vs benchmark
9%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (22)
Enhanced COPD Management in Suspected Lung Cancer Patients
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
Benefit of Spectral Information in Patients Suspected for Lung Cancer
Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors
Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors
Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer
Confocal Laser Endomicroscopy VERification
(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis
Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies
Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy
Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery
Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy